PharmaDepth
beta
Catalyst
Company
Drug
Company Information
Neurocrine Biosciences, Inc. (NBIX)
Overview
Products
Trials
Market Cap
$13.06B
Revenue TTM
Earnings Date
2025-02-05
Website
https://www.neurocrine.com
Upcoming PDUFA Dates
No upcoming PDUFAs found
Upcoming Trial Readouts
Feature coming soon
Upcoming Patent Expirations
Brand Name
Patent Number
Expire Date
INGREZZA
8357697
11/8/2027
INGREZZA SPRINKLE
8357697
11/8/2027
INGREZZA
8039627
4/11/2031
INGREZZA SPRINKLE
8039627
4/11/2031
INGREZZA
10065952
10/28/2036
INGREZZA
10844058
10/28/2036
INGREZZA
10851103
10/28/2036
INGREZZA
10851104
10/28/2036
INGREZZA SPRINKLE
10065952
10/28/2036
INGREZZA SPRINKLE
10844058
10/28/2036
INGREZZA SPRINKLE
10851103
10/28/2036
INGREZZA SPRINKLE
10851104
10/28/2036
INGREZZA
10906902
12/22/2036
INGREZZA
10906903
12/22/2036
INGREZZA
10919892
12/22/2036
INGREZZA SPRINKLE
10906902
12/22/2036
INGREZZA SPRINKLE
10906903
12/22/2036
INGREZZA SPRINKLE
10919892
12/22/2036
INGREZZA
10857137
10/10/2037
INGREZZA
10857148
10/10/2037
INGREZZA
10874648
10/10/2037
INGREZZA
10912771
10/10/2037
INGREZZA
10952997
10/10/2037
INGREZZA
10993941
10/10/2037
INGREZZA
11040029
10/10/2037
INGREZZA
11439629
10/10/2037
INGREZZA SPRINKLE
10857137
10/10/2037
INGREZZA SPRINKLE
10857148
10/10/2037
INGREZZA SPRINKLE
10874648
10/10/2037
INGREZZA SPRINKLE
10912771
10/10/2037
INGREZZA SPRINKLE
10952997
10/10/2037
INGREZZA SPRINKLE
10993941
10/10/2037
INGREZZA SPRINKLE
11040029
10/10/2037
INGREZZA SPRINKLE
11439629
10/10/2037
INGREZZA
11026939
9/18/2038
INGREZZA
11311532
9/18/2038
INGREZZA SPRINKLE
11026939
9/18/2038
INGREZZA SPRINKLE
11311532
9/18/2038
INGREZZA
11654142
11/14/2038
INGREZZA SPRINKLE
11654142
11/14/2038
INGREZZA
11026931
8/14/2039
INGREZZA SPRINKLE
11026931
8/14/2039
INGREZZA
10940141
8/10/2040
INGREZZA SPRINKLE
10940141
8/10/2040